CM
IBB icon

Columbus Macro’s iShares Biotechnology ETF IBB Stock Holding History

Columbus Macro’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$649K Sell
3,842
-14,983
-80% -$2.56M 0.07% 155
2025
Q4 		$3.18M Buy
+18,825
New +$3.06M 0.35% 95
2024
Q3 		– Sell
-10,271
Closed -$1.41M – 187
2024
Q2 		$1.41M Buy
+10,271
New +$1.37M 0.55% 63
2023
Q1 		– Sell
-8,063
Closed -$1.06M – 171
2022
Q4 		$1.06M Buy
+8,063
New +$1.04M 0.41% 84

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Columbus Macro's IBB Position: Q1 2026 in Review

Columbus Macro reduced its iShares Biotechnology ETF (IBB) stake by 80% in Q1 2026, selling an estimated $2.56M and leaving 3,842 shares worth $649K. The position accounts for 0.07% of the portfolio, ranked #155.

Columbus Macro first reported a position in IBB in Q4 2022 and has held it in 4 quarters since. The position peaked at $3.18M in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Columbus Macro held 3,842 shares of iShares Biotechnology ETF worth $649K as of Q1 2026.
  • Columbus Macro sold 14,983 iShares Biotechnology ETF shares in Q1 2026, an estimated $2.56M.
  • iShares Biotechnology ETF made up 0.07% of Columbus Macro's portfolio in Q1 2026, its #155 holding.
  • Columbus Macro first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 4 quarters since.
  • Columbus Macro's iShares Biotechnology ETF position peaked at $3.18M in Q4 2025.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Columbus Macro's 13F filing for Q1 2026, filed 21 Apr 2026.